News Archives - AINewsWire

FridaySep 05, 2025 1:00 pm

AINewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) to Present at Centurion One Capital Summit in Bahamas

Beeline Holdings (NASDAQ: BLNE), a digital mortgage platform redefining the path to homeownership, today announced it will present at the Centurion One Capital Summit in the Bahamas on Oct. 28–29, 2025. CEO and Co-Founder Nick Liuzza, CFO Chris Moe, and COO Jessica Kennedy will represent the company, highlighting Beeline’s growth strategy, execution, and long-term market opportunity to investors attending the event. To view the full press release, visit https://ibn.fm/n4my3 About Beeline Holdings, Inc. Beeline Holdings, Inc. is a trailblazing mortgage fintech transforming the way people access property financing. Through its fully digital, AI-powered platform, Beeline delivers a faster, smarter path to…

ThursdaySep 04, 2025 10:20 am

AINewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Achieves Debt-Free Status Ahead of Schedule

Beeline Holdings (NASDAQ: BLNE), a digital mortgage platform redefining the path to homeownership, announced it has paid down all outstanding debt, excluding warehouse lines used to fund mortgage transactions. The Company, which began 2025 with more than $7 million in debt, has now cleared all notes payable and secured credit facilities, including senior secured debentures, achieving debt-free status earlier than expected. With a strengthened balance sheet, Beeline is focused on accelerating growth and innovation, supported by cost optimization, new product launches, and revenue momentum. The Company expects to reach cash flow positive operations by Q1 2026. To view the full press…

ThursdaySep 04, 2025 10:18 am

AINewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Subsidiary Publishes Landmark Primer on Oncology Real-World Evidence

Fifty 1 Labs (OTC: FITY) through its subsidiary Fifty1 AI Labs, announced the publication of a landmark technical primer on transportability methods in oncology real-world evidence (RWE) in the Journal of Comparative Effectiveness Research. Co-authored by CTO Alind Gupta and CEO Paul Arora, the paper showcases how advanced statistical and AI-driven frameworks can bridge data gaps, accelerate health technology assessments, and improve global access to life-saving therapies. With the oncology RWE market projected to expand from $789 million in 2024 to $3.51 billion by 2035 at a CAGR of 14.7%, the publication underscores Fifty1 Labs’ leadership in advancing drug repurposing…

ThursdaySep 04, 2025 10:10 am

AINewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Subsidiary Wins Drone Services Contracts with Florida Utilities

Safe Pro Group (NASDAQ: SPAI), a provider of AI-powered defense and security solutions, announced that its Mission Critical Unmanned Solutions(R) subsidiary, Airborne Response, has been awarded two aerial drone services contracts by Florida power utilities serving millions of residents. The agreements cover disaster response imagery to assess storm damage to power grid infrastructure as well as “blue sky” condition assessments. With NOAA forecasting a 60% chance of above-average Atlantic storm activity in 2025, Airborne’s Florida-compliant drone fleet is positioned to support utilities in maintaining reliable power while expanding its role as a leading provider of infrastructure inspection, monitoring, and emergency…

WednesdaySep 03, 2025 1:45 pm

AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) Completes FDA Type C Meeting, Gains Guidance for Planned Pediatric CNS Cancer Trial

Lantern Pharma (NASDAQ: LTRN), an AI-driven clinical-stage oncology company, announced the completion of a Type C meeting with the U.S. Food and Drug Administration, which provided guidance on the regulatory pathway and design of a planned pediatric trial targeting CNS cancers, including Atypical Teratoid Rhabdoid Tumor (ATRT). The FDA supported Lantern’s proposal for a parallel ATRT cohort and the potential inclusion of spironolactone as a combination agent with LP-184/STAR-001, the company’s lead investigational therapy. Lantern, through its subsidiary Starlight Therapeutics, will submit an IND amendment reflecting the feedback, with trial initiation targeted for Q1 2026. The program holds Rare Pediatric…

WednesdaySep 03, 2025 1:33 pm

AINewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Spotlighted in Forbes Feature on AI and Web3 Convergence

Datavault AI (NASDAQ: DVLT), a leader in tokenized data and Web3 infrastructure, was recently featured in Forbes in an article titled “How AI Is Ushering In A New Age For Web3” (Aug. 31, 2025). The piece highlights DVLT’s role in merging blockchain’s decentralized architecture with the adaptive intelligence of AI, underscoring how its secure, user-centric data platform enables seamless integration of tokenized assets and personalized digital interactions. As enterprises and developers look to bridge trust, transparency, and efficiency across decentralized ecosystems, DVLT is positioning itself as a cornerstone for the next generation of Web3 infrastructure. The Forbes coverage emphasized that…

WednesdaySep 03, 2025 10:31 am

AINewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Closes $31 Million Acquisition of Holiday Inn Property to Launch AI-Driven Hospitality Platform

Nightfood Holdings (OTCQB: NGTF), a hospitality technology company leveraging AI-powered robotics and strategic acquisitions to transform hotel operations, announced the closing of its $31 million share exchange agreement to acquire Victorville Treasure Holdings, LLC, owner of a 155-room Holiday Inn in Victorville, Calif. The deal marks Nightfood’s first completed hotel acquisition, with a second nearing completion, and establishes the Victorville property as the Company’s Robotics-as-a-Service innovation site. Initial automation solutions, including Skytech’s Laundry Helper robot, have already been deployed, with future phases to expand across housekeeping, foodservice, and front-of-house functions to create a scalable “Smart Hotel” model. CEO Jimmy Chan…

TuesdaySep 02, 2025 3:06 pm

AINewsBreaks – BluSky AI Inc. (OTCID: BSAI) Acquires 36-Acre Colorado Site for 15 MW AI Data Center Deployment

BluSky AI (OTCID: BSAI), a Neocloud company providing GPU-as-a-Service through its modular SkyMod data centers, announced the execution of a Purchase and Sale Agreement with Snowy River Ranches LLC for a 36.06-acre parcel in Huerfano County, Colo. The Walsenburg property, located at Hwy 69/Indian Pool Ranch, is positioned to support up to 15 megawatts of scalable compute capacity and offers direct access to regional energy infrastructure and transmission corridors. CEO Trent D’Ambrosio said the acquisition strengthens BluSky’s national expansion strategy, aligning compute growth with local economic development and environmental stewardship. The site will be developed under state and county permitting…

TuesdaySep 02, 2025 10:40 am

AINewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Reports Strong Q2/25 Results, Targets Profitability in Early 2026

Beeline Holdings (NASDAQ: BLNE), a U.S.-based digital mortgage lender, reported strong results for the second quarter of 2025, highlighting both financial and operational progress. The company posted US$1.7 million in revenue for the quarter ended June 30, representing a 27% increase quarter-over-quarter, while cutting operating costs by 40% to US$5.6 million. Net loss narrowed to US$4.1 million, a 68% improvement from the prior quarter, and adjusted EBITDA also improved. Beeline reduced debt by US$2.7 million during the quarter, bringing its year-to-date repayment to US$6.2 million, and ended Q2 with US$6.3 million in cash. Management reiterated its expectation to reach profitability by…

ThursdayAug 28, 2025 3:04 pm

AINewsBreaks – Lantern Pharma Inc. (NASDAQ: LTRN) Advances Predictive Power in Cancer Drug Development

Lantern Pharma (NASDAQ: LTRN) recently unveiled a new artificial intelligence module designed to predict the effectiveness of cancer treatment combinations involving DNA-damaging agents (“DDAs”) and DNA damage response inhibitors (“DDRis”). “The technology is integrated into the company’s RADR(R) platform, which supports AI-guided drug development,” reads a recent article. “By embedding this technology into RADR(R), Lantern Pharma continues to position itself as a developer of data-driven approaches to oncology drug development. The module not only improves the chances of clinical success but also aligns with growing industry efforts to personalize cancer treatments based on molecular and genetic profiles.” To view the…

AINewsWire provides insights in the emerging sector of Artificial Intelligence.

Contact us: (512) 354-7000

Breaks Categories: News